ICON plc
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
ICON plc
Aug 28, 2024, 04:31 |
Blog
Leveraging Healthcare Intelligence to Increase Diversity of Oncology Clinical Trials - ICON
ICON plc shared on LinkedIn: "Healthcare technology and data availability now offer innovative solutions to…
Jul 24, 2024, 01:01 |
Blog
Webinar on regulatory submission writing for NDA success - ICON plc
ICON plc shared a post on LinkedIn: ''Join us on 10 September 2024, for an…
Jun 11, 2024, 10:07 |
Blog
Rajkapoor Kamaludeen: We're currently hiring at ICON
Rajkapoor Kamaludeen, Talent Acquisition Recruiter at ICON plc, shared a post on LinkedIn: “Join our…
Jun 3, 2024, 11:57 |
Societies
Tanja Obradovic: Very dynamic day at ASCO2024
Tanja Obradovic shared a post on LinkedIn: "Very dynamic ASCO2024 day as we learned quite…
May 27, 2024, 04:41 |
Blog
Brooke Austen: ICON hosted event to discuss common challenges faced by the biotech industry
Tanja Obradovic shared a post by Brooke Austen, Business Development Analyst at ICON plc, on LinkedIn: "Great…
May 22, 2024, 02:47 |
Insight
Visit ICON plc at ASCO24, booth 30119 to learn about One Search - ICON plc
Tanja Obradovic shared a post by ICON plc on LinkedIn, adding: “ASCO204 is almost to start.…
May 20, 2024, 06:16 |
Blog
ICON plc - How a flexible approach to clinical trials is reimagining the patient journey
ICON plc shared a post on LinkedIn: "Read our latest article in Pharmaceutical Executive to consider…
May 17, 2024, 13:27 |
Blog
ICON plc's role as a trusted partner in navigating industry changes
ICON plc posted on LinkedIn: "Curious about the future of clinical trials? Don't miss our…
May 14, 2024, 11:07 |
Blog
Tanja Obradovic: At ASCO 2024 at the ICON plc booth we share thoughts on latest in cancer treatment innovation
Tanja Obradovic shared a post by ICON plc on LinkedIn, adding: ''This year we are certain…
Jan 24, 2024, 08:04 |
Blog
Tanja Obradovic: Clinical development includes the need to have critical focus on inclusion and diversity
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc, shared a post by…
All:
10
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube